Financials
Financial year 2025
AS PHARMA CONSULTING from Fleurus, company number BE0802302143, closed financial year 2025 with a result of € 28,563 after tax. For that financial year AS PHARMA CONSULTING recorded a gross margin of € 81,694 and equity of € 129,404. Compared with financial year 2024, the result moved from € 97,340 to € 28,563. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 129,404
▲ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 28,563
▼ 71% vs 2024
Profit after tax over the fiscal year.
€ 133,874
▲ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 125,904.
People and assets in 2025
€ 602
▼ 46% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,322
▲ 117% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,332
▲ 74% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 137,674 | € 81,694 | ▼ 41% |
| Profit after taxes | € 97,340 | € 28,563 | ▼ 71% |
| Equity | € 100,840 | € 129,404 | ▲ 28% |
| Total debts | € 41,855 | € 56,113 | ▲ 34% |
| Cash | € 102,577 | € 133,874 | ▲ 31% |
| Retained profit | € 97,340 | € 125,904 | ▲ 29% |
| Balance sheet total | € 142,695 | € 185,517 | ▲ 30% |
Key figures of AS PHARMA CONSULTING, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AS PHARMA CONSULTING?
What happened at AS PHARMA CONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 28,563 (▼ 71% vs 2024). filed late Source: NBB ↗
- New establishment in Fleurus. KBO
- Start of the company according to the CBE. KBO
In short
From € 97,340 profit in 2024 to € 28,563 profit in 2025.
Paid € 43,191 in corporate taxes since 2024.
Best year ever: 2024, with € 97,340 profit.
Establishments
Establishment units
Physical locations of this company
Avenue de la Gare(FL) 14 box 5
6220 Fleurus
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0802.302.143
- VAT number
- BE 0802.302.143
- Registered office
- Avenue de la Gare(FL) 14 bus 5, 6220 Fleurus
- Names & denominations
- AS PHARMA CONSULTING
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 June 2023
- Peppol
- Active · Active since 15 Jan 2026
- Contact
- [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Detailhandel in cosmetica en toiletartikelen
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering